Negócios · 28/04/20161 min de leitura
New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship; Correction
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) published a document in the Federal Register of April 18, 2016 (81 FR 22520), amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during January and February 2016. That rule included two amendatory instructions that cited incorrect sections of 21 CFR part 524.